Relation of atrial fibrillation burden and N-terminal pro-brain natriuretic peptide

American Journal of Cardiology

Volumn 111, Issue 9, 2013, Pages 1315-1318

  Plitt, David C ^a   Chung, Eugene H ^a   Mounsey, John P ^a   Schwartz, Jennifer D ^a   Pursell, Irion W ^a   Gehi, Anil K ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADULT; ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HEART RHYTHM; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE;

ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; NORTH CAROLINA; PEPTIDE FRAGMENTS; PROGNOSIS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; SEVERITY OF ILLNESS INDEX;

EID: 84876734884     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.01.273     Document Type: Article

References (15)

1. P.T. Ellinor, A.F. Low, K.K. Patton, M.A. Shea, and C.A. Macrae Discordant atrial natriuretic peptide and brain natriuretic peptide levels in lone atrial fibrillation J Am Coll Cardiol 45 2005 82 86
2. A. Rossi, M. Enriquez-Sarano, J.C. Burnett Jr., A. Lerman, M.D. Abel, and J.B. Seward Natriuretic peptide levels in atrial fibrillation: a prospective hormonal and Doppler-echocardiographic study J Am Coll Cardiol 35 2000 1256 1262
3. P. Jourdain, M. Bellorini, F. Funck, Y. Fulla, N. Guillard, J. Loiret, B. Thebault, N. Sadeg, and M. Desnos Short-term effects of sinus rhythm restoration in patients with lone atrial fibrillation: a hormonal study Eur J Heart Fail 4 2002 263 267
4. B. Wozakowska-Kaplon Effect of sinus rhythm restoration on plasma brain natriuretic peptide in patients with atrial fibrillation Am J Cardiol 93 2004 1555 1558
5. V. Danicek, N. Theodorovich, S. Bar-Chaim, A. Miller, Z. Vered, N. Koren-Morag, N. Uriel, I. Czuriga, A. Shopen, N. Brantriss, and E. Kaluski Sinus rhythm restoration after atrial fibrillation: the clinical value of N-terminal pro-BNP measurements Pacing Clin Electrophysiol 31 2008 955 960
6. T. Yamada, Y. Murakami, T. Okada, N. Yoshida, J. Toyama, Y. Yoshida, N. Tsuboi, Y. Inden, M. Hirai, and T. Murohara Plasma brain natriuretic peptide level after radiofrequency catheter ablation of paroxysmal, persistent, and permanent atrial fibrillation Europace 9 2007 770 774
7. T. Date, T. Yamane, K. Inada, S. Matsuo, S. Miyanaga, K. Sugimoto, K. Shibayama, I. Taniguchi, and S. Mochizuki Plasma brain natriuretic peptide concentrations in patients undergoing pulmonary vein isolation Heart 92 2006 1623 1627
8. K. Kurosaki, H. Tada, T. Hashimoto, S. Ito, K. Miyaji, S. Naito, S. Oshima, and K. Taniguchi Plasma natriuretic peptide concentrations as a predictor for successful catheter ablation in patients with drug-refractory atrial fibrillation Circ J 71 2007 313 320
9. R.M. Lang, M. Bierig, R.B. Devereux, F.A. Flachskampf, E. Foster, P.A. Pellikka, M.H. Picard, M.J. Roman, J. Seward, J.S. Shanewise, S.D. Solomon, K.T. Spencer, M.S. Sutton, W.J. Stewart Chamber Quantification Writing Group American Society of Echocardiography's Guidelines and Standards Committee, and European Association of Echocardiography Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463
10. B. Wozakowska-Kaplon, R. Bartkowiak, U. Grabowska, and G. Janiszewska B-type natriuretic peptide level after sinus rhythm restoration in patients with persistent atrial fibrillation - clinical significance Kardiol Pol 68 2010 781 786
11. K.P. Letsas, G.S. Filippatos, L.K. Pappas, C.C. Mihas, V. Markou, I.P. Alexanian, M. Efremidis, A. Sideris, A.S. Maisel, and F. Kardaras Determinants of plasma NT-pro-BNP levels in patients with atrial fibrillation and preserved left ventricular ejection fraction Clin Res Cardiol 98 2009 101 106
12. G.M. Felker, V. Hasselblad, A.F. Hernandez, and C.M. O'Connor Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials Am Heart J 158 2009 422 430
13. J. Koglin, S. Pehlivanli, M. Schwaiblmair, M. Vogeser, P. Cremer, and W. vonScheidt Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure J Am Coll Cardiol 38 2001 1934 1941
14. T.J. Wang, M.G. Larson, D. Levy, E.J. Benjamin, E.P. Leip, T. Omland, P.A. Wolf, and R.S. Vasan Plasma natriuretic peptide levels and the risk of cardiovascular events and death N Engl J Med 350 2004 655 663
15. J. Bergler-Klein, U. Klaar, M. Heger, R. Rosenhek, G. Mundigler, H. Gabriel, T. Binder, R. Pacher, G. Maurer, and H. Baumgartner Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis Circulation 109 2004 2302 2308